Supplements for people on metformin

B12 monitoring (essential), CoQ10, magnesium, and the hypoglycemia-interaction list. Adjunct, not substitute, for your diabetes care plan.

Metformin is one of the most widely-prescribed medications in the world, used in type 2 diabetes, pre-diabetes, PCOS, and (off-label) in metabolic risk reduction. It is generally safe and well tolerated — but chronic use depletes vitamin B12, an effect now well established and recommended for periodic monitoring by the ADA. A handful of other supplements stack reasonably with metformin; several stack dangerously and need careful glucose monitoring or avoidance. This page is for adults already taking metformin under a clinician's care; supplements do not replace metformin or modify dosing decisions.
88
Vitamin B12 (methylcobalamin)
Depleted by metformin · Monitor annually · Tier 1
Tier 1
85
Magnesium glycinate
Often low in diabetes · Glycaemic control adjunct
Tier 1
75
CoQ10 (Ubiquinol)
May be modestly reduced on metformin · Cardiac adjunct
Tier 2
82
Omega-3 EPA/DHA
Triglycerides ↓ · Cardiovascular foundation
Tier 1
83
Vitamin D3
Often deficient in metabolic disease cohorts
Tier 1
85
Psyllium husk
Adjunctive glycaemic and lipid effect · GI tolerability
Tier 1
72
Alpha-lipoic acid
Diabetic neuropathy · 600 mg/day
Tier 2

The metformin-companion stack — rationale by ingredient

Vitamin B12 (methylcobalamin or hydroxocobalamin) — the non-negotiable one

Metformin reduces B12 absorption via interference with calcium-dependent terminal-ileum uptake. The 2024 ADA Standards of Care recommend periodic B12 monitoring in long-term metformin users, especially those with anaemia or neuropathy. Test serum B12 (and methylmalonic acid if borderline) every 1–2 years. Supplement at 500–1000 mcg/day if low or borderline. The B12 depletion effect is dose- and duration-dependent — patients on >1500 mg/day for >5 years are higher-risk.

Magnesium glycinate 300–400 mg elemental nightly

Low magnesium status is more common in type 2 diabetes and is associated with worse insulin sensitivity. The 2025 meta-analysis on magnesium and glycaemic control suggests modest improvement in HbA1c with supplementation in deficient patients. The glycinate form is the most GI-friendly. Particularly useful at night for sleep and muscle cramps.

CoQ10 (ubiquinol) 100–200 mg/day

Modest evidence that metformin reduces CoQ10 levels via mitochondrial-complex-I effects, though smaller than the statin effect. Worth considering in patients on metformin + statin combination or with documented exercise intolerance. Take with a fat-containing meal for absorption.

Omega-3 EPA/DHA 1.5–2 g/day

Foundational cardiovascular adjunct in diabetes. Reduces triglycerides and supports overall lipid management. Pair with a real cardiovascular care plan.

Vitamin D3 to a 25-OH-D of 30–50 ng/mL

Deficiency is more common in type 2 diabetes cohorts. Test first; supplement to the normal range. Routine high-dose empirical dosing is not appropriate.

Psyllium husk 5–10 g/day

Soluble fibre with FDA cholesterol claim and modest glycaemic effect (reduces postprandial glucose excursions). Take separately from metformin and other medications by 1–2 hours to avoid binding interactions.

Alpha-lipoic acid 600 mg/day (if neuropathy)

Best-evidenced supplement for diabetic peripheral neuropathy. Modest improvement in nerve-conduction studies and patient-reported pain at 600 mg/day. Use only if you have neuropathic symptoms; not a routine prophylactic.

Watch carefully or skip — hypoglycaemia stacking

Educational reference, not medical advice. Discuss any supplement change with your prescribing physician. If you take metformin and notice new symptoms — fatigue, memory complaints, tingling in hands or feet, paleness — ask about a B12 test. Glucose monitoring before adding any blood-sugar-lowering supplement is essential.

Sources

  1. de Jager J, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181. PMID: 20488910
  2. American Diabetes Association. Standards of Medical Care in Diabetes — 2024. Diabetes Care. 2024;47(Suppl 1).
  3. Veronese N, et al. Magnesium and glycemic control: a 2025 meta-analysis. Nutrients. 2025;17(2):350.
  4. Liu Q, et al. Berberine and metformin combination on glycaemic control: a systematic review. Phytother Res. 2022;36(3):1116–1126. PMID: 34958160
  5. Ziegler D, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care. 2011;34(9):2054–2060. PMID: 21775755
  6. Aroda VR, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754–1761. PMID: 26900641